0.14 USD
↘ 0.00 (1.45%)LIVE (AS OF 11:54 AM EST)
Shares of TScan Therapeutics, Inc. Common Stock (TCRX) are trading at $0.14. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest TCRX is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Nov 16, 2026.